Sector Gamma AS’s Atara Biotherapeutics ATRA Stock Holding History

Sector Gamma AS’s Portfolio ATRA Stock Details ATRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4,949	Closed	-$964K	–	33
2022 Q2	$964K	Hold	4,949	–	–	0.22%	36
2022 Q1	$1.15M	Buy	+4,949	New	+$1.58M	0.25%	39

Other funds holding ATRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sector Gamma AS's ATRA Position: Q3 2022 in Review

Sector Gamma AS sold out of Atara Biotherapeutics (ATRA) in Q3 2022, closing a stake of 4,949 shares — an estimated $964K sold.

Sector Gamma AS first reported a position in ATRA in Q1 2022 and held it in 2 quarters. The position peaked at $1.15M in Q1 2022. 154 funds tracked by Wall St. Rank hold ATRA as of Q3 2022.

Sector Gamma AS reported no remaining Atara Biotherapeutics position as of Q3 2022 after selling out during the quarter.
Sector Gamma AS sold 4,949 Atara Biotherapeutics shares in Q3 2022, an estimated $964K.
Sector Gamma AS first reported a position in Atara Biotherapeutics in Q1 2022 and held it in 2 quarters.
Sector Gamma AS's Atara Biotherapeutics position peaked at $1.15M in Q1 2022.
154 funds tracked by Wall St. Rank held Atara Biotherapeutics as of Q3 2022.

Based on Sector Gamma AS's 13F filing for Q3 2022, filed 9 Nov 2022.